Rafael Holdings RFL
NYSE RFL
$1.53 +0.03 (+2.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rafael Holdings (RFL) Gains from Equity Investments (2017 - 2018)

Updated

Rafael Holdings (RFL) recorded Gains from Equity Investments of $37,000 in FY2019 (year ended Jul 31, 2019), compared with -$104,000 in FY2018.

Analysis

Rafael Holdings (RFL) Gains from Equity Investments (2017 - 2018) Analysis & Trends

  • Per Business Quant data, RFL's Gains from Equity Investments was -$104,000 in FY2018 and -$113,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Rafael Holdings 78.35 Mn 83.76 Mn 163,000.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2018 -184,000.00
Apr 30, 2018 519,000.00
Jan 31, 2018 -335,000.00
Oct 31, 2017 -104,000.00
API Access

Rafael Holdings Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=RFL&period=max&api_key=YOUR_API_KEY